Cipher Drug Patent Portfolio
Cipher owns 1 orange book drug protected by 5 US patents Given below is the list of Cipher's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9895388 | Methods and compositions useful for controlling cutaneous mites | 25 Nov, 2033 | Active |
| US7030095 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs | 02 Jul, 2021 | Expired |
| US6063771 | Formulations for controlling human lice | 22 Jun, 2019 | Expired |
| US6342482 | Formulations for controlling human lice | 22 Jun, 2019 | Expired |
| US5496931 | Insecticide and miticide A83543 compounds and their method of production by fermentation | 05 Mar, 2013 | Expired |
Latest Legal Activities on Cipher's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Cipher.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 11 Aug, 2021 | US9895388 |
|
Expire Patent
Critical
| 14 May, 2018 | US7030095 |
|
Recordation of Patent Grant Mailed
Critical
| 20 Feb, 2018 | US9895388 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 20 Feb, 2018 | US9895388 |
|
Application ready for PDX access by participating foreign offices
Critical
| 20 Feb, 2018 | US9895388 |
|
Email Notification
Critical
| 01 Feb, 2018 | US9895388 |
|
Issue Notification Mailed
Critical
| 31 Jan, 2018 | US9895388 |
| Dispatch to FDC | 12 Jan, 2018 | US9895388 |
|
Application Is Considered Ready for Issue
Critical
| 12 Jan, 2018 | US9895388 |
|
Issue Fee Payment Verified
Critical
| 10 Jan, 2018 | US9895388 |
|
Issue Fee Payment Received
Critical
| 10 Jan, 2018 | US9895388 |
|
Maintenance Fee Reminder Mailed
Critical
| 27 Nov, 2017 | US7030095 |
|
Mail Notice of Allowance
Critical
| 19 Oct, 2017 | US9895388 |
|
Email Notification
Critical
| 19 Oct, 2017 | US9895388 |
|
Electronic Review
Critical
| 19 Oct, 2017 | US9895388 |
Cipher's Family Patents
Cipher Drug List
Given below is the complete list of Cipher's drugs and the patents protecting them.
1. Natroba
Natroba is protected by 5 patents, out of which 4 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9895388 | Methods and compositions useful for controlling cutaneous mites |
25 Nov, 2033
(8 years from now)
| Active |
| US7030095 | Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs |
02 Jul, 2021
(3 years ago)
| Expired |
| US6063771 | Formulations for controlling human lice |
22 Jun, 2019
(5 years ago)
| Expired |
| US6342482 | Formulations for controlling human lice |
22 Jun, 2019
(5 years ago)
| Expired |
| US5496931 | Insecticide and miticide A83543 compounds and their method of production by fermentation |
05 Mar, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Natroba's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List